Related Experiment Video
Updated: Jun 2, 2026

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
Published on: September 19, 2025
Cellular therapies: what is still missing?
1Miltenyi Biotec GmbH, Bergisch Gladbach, Germany. pinkerk@hotmail.com
Abstract:
Yeagy and colleagues present long-term data from a preclinical model of cystinosis after hematopoietic stem cell transplantation. The results suggest a therapeutic benefit independent of target tissue differentiation but dependent on the level of bone marrow chimerism. The mode of action remains mysterious, but positive effects are seen. Although the work presents a potential therapeutic option for an otherwise dismal disease, the search for the mechanism of action in cellular therapies continues.
Insights
Hematopoietic stem cell transplantation shows therapeutic benefits for cystinosis, independent of tissue differentiation. Success depends on bone marrow chimerism levels, though the exact mechanism requires further investigation.
Area of Science:
- * Preclinical research in rare genetic disorders.
- * Investigating cellular therapies for metabolic diseases.
Background:
- * Cystinosis is a severe inherited metabolic disease.
- * Hematopoietic stem cell transplantation (HSCT) is a potential treatment for cystinosis.
- * Long-term data on HSCT efficacy in preclinical models are limited.
Discussion:
- * HSCT demonstrated therapeutic benefits in a preclinical cystinosis model.
- * Treatment efficacy correlated with bone marrow chimerism levels.
- * The precise mechanism of action for HSCT in cystinosis remains unclear.
Key Insights:
- * Therapeutic effects of HSCT were observed irrespective of target tissue differentiation.
- * Bone marrow chimerism is a critical factor for HSCT success in this model.
- * Positive outcomes suggest HSCT as a viable therapeutic strategy.
Outlook:
- * Further research is needed to elucidate the mechanism of action of HSCT in cystinosis.
- * Investigating cellular therapies for rare genetic metabolic disorders is ongoing.
- * This study provides a foundation for exploring HSCT as a treatment for cystinosis.
Related Concept Videos
Tumor Immunotherapy
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Gene Therapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Microorganisms in Medicine and Therapeutics
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
